Atossa Genetics (ATOS)
(Delayed Data from NSDQ)
$0.85 USD
-0.03 (-3.55%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $0.84 -0.01 (-1.03%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Atossa Genetics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Instruments industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ATOS 0.85 -0.03(-3.55%)
Will ATOS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ATOS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ATOS
Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?
All You Need to Know About Atossa Genetics (ATOS) Rating Upgrade to Buy
ATOS: What are Zacks experts saying now?
Zacks Private Portfolio Services
TCMD Stock Rises 20% in Three Months: Should You Buy, Hold or Sell?
Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?
Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?
Other News for ATOS
Is ATOS showing upside potential? 200 Day Moving Average Support shows up after sinking 3.55%
ATOS Crossed Above 200 Day Moving Average on September 18
Atossa Therapeutics: Strategic Advancements and Strong Financial Position Signal Promising Future
ATOS forms 50 Day Moving Average Support on September 17
Atossa Therapeutics appoints CORE IR for investor relations